Guangzhou Ruixin Biotechnological Co., LTD
2 clinical trials · Sponsor
◉ Watch Guangzhou Ruixin Biotechnological Co., LTD
| Record | Firm | Date |
|---|---|---|
| INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer (NCT06747832) | Guangzhou Ruixin Biotechnological Co., LTD | 2024-12-15 |
| Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia (NCT06702098) | Guangzhou Ruixin Biotechnological Co., LTD | 2024-11-25 |
Track Guangzhou Ruixin Biotechnological Co., LTD automatically
Every clearance here is in the API, with alerts when new ones post.